Rescue experiments using the AKT activator SC79 significantly reversed daphnoretin's anti-tumor effects on GBM cells, inhibiting proliferation and metastasis, inducing apoptosis, and downregulating the PI3K/AKT signaling pathway in vitro. Here, AKT1 is linked to glioblastoma.